|
|
||||||||
1 Renal Section, Evans Memorial Department of Clinical Research, Department of Medicine, 4 Naval Blood Research Laboratory, and 2 Department of Pathology, Boston University Medical Center, Boston 02118; 3 Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115; and 5 Section of Nephrology, Biological Sciences Division, University of Chicago, Chicago, Illinois 60637
The
immunosuppressive effect of rapamycin is mediated by inhibition of
interleukin-2-stimulated T cell proliferation. We report for the first
time that rapamycin also inhibits growth factor-induced proliferation
of cultured mouse proximal tubular (MPT; IC50 ~1 ng/ml)
cells and promotes apoptosis of these cells by impairing the
survival effects of the same growth factors. On the basis of these in
vitro data, we tested the hypothesis that rapamycin would impair
recovery of renal function after ischemic acute renal failure
induced in vivo by renal artery occlusion (RAO). Rats given daily
injections of rapamycin or vehicle were subjected to RAO or sham
surgery. Rapamycin had no effect on the glomerular filtration rate
(GFR) of sham-operated animals. In rats subjected to RAO, GFR fell to
comparable levels 1 day later in vehicle- and rapamycin-treated rats
(0.25 ± 0.08 and 0.12 ± 0.05 ml · min
1 · 300 g
1,
respectively) (P = not significant). In vehicle-treated
rats subjected to RAO, GFR increased to 0.61 ± 0.08 ml · min
1 · 300 g
1 on
day 3 (P < 0.02 vs. day 1) and
then rose further to 0.99 ± 0.09 ml · min
1 · 300 g
1 on
day 4 (P < 0.02 vs. day 3). By
contrast, GFR did not improve in rapamycin-treated rats subjected to
RAO over the same time period. Rapamycin also increased
apoptosis of tubular cells while markedly reducing their
proliferative response after RAO. Furthermore, rapamycin inhibited
activation of 70-kDa S6 protein kinase (p70S6k) in cultured
MPT cells as well as in the renal tissue of rats subjected to
RAO. We conclude that rapamycin severely impairs the recovery of renal
function after ischemia-reperfusion injury. This effect
appears to be due to the combined effects of increased tubular cell
loss (via apoptosis) and profound inhibition of the regenerative response of tubular cells. These effects are likely mediated by inhibition of p70S6k.
ischemia; proliferation; 70-kDa S6 protein kinase
This article has been cited by other articles:
![]() |
T. Weimbs Polycystic kidney disease and renal injury repair: common pathways, fluid flow, and the function of polycystin-1 Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1423 - F1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Letavernier, P. Bruneval, C. Mandet, J.-P. D. Van Huyen, M.-N. Peraldi, I. Helal, L.-H. Noel, and C. Legendre High Sirolimus Levels May Induce Focal Segmental Glomerulosclerosis De Novo Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 326 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Lock, S. H. Sacks, and M. G. Robson Rapamycin at subimmunosuppressive levels inhibits mesangial cell proliferation and extracellular matrix production Am J Physiol Renal Physiol, January 1, 2007; 292(1): F76 - F81. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xie and Q. Guo Par-4 is a novel mediator of renal tubule cell death in models of ischemia-reperfusion injury Am J Physiol Renal Physiol, January 1, 2007; 292(1): F107 - F115. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Keller, C. Daniel, H. Schocklmann, K.-H. Endlich, D. Kerjaschki, R. J. Johnson, and C. Hugo Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2724 - 2735. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Wahl, A. L. Serra, M. Le Hir, K. D. Molle, M. N. Hall, and R. P. Wuthrich Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD) Nephrol. Dial. Transplant., March 1, 2006; 21(3): 598 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G.B. Bonegio, R. Fuhro, Z. Wang, C. R. Valeri, C. Andry, D. J. Salant, and W. Lieberthal Rapamycin Ameliorates Proteinuria-Associated Tubulointerstitial Inflammation and Fibrosis in Experimental Membranous Nephropathy J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2063 - 2072. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-P. Marti and F. J. Frey Nephrotoxicity of rapamycin: an emerging problem in clinical medicine Nephrol. Dial. Transplant., January 1, 2005; 20(1): 13 - 15. [Full Text] [PDF] |
||||
![]() |
Y. Tao, J. Kim, R. W. Schrier, and C. L. Edelstein Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease J. Am. Soc. Nephrol., January 1, 2005; 16(1): 46 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Loverre, P. Ditonno, A. Crovace, L. Gesualdo, E. Ranieri, P. Pontrelli, G. Stallone, B. Infante, A. Schena, S. Di Paolo, et al. Ischemia-Reperfusion Induces Glomerular and Tubular Activation of Proinflammatory and Antiapoptotic Pathways: Differential Modulation by Rapamycin J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2675 - 2686. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Fervenza, P. M. Fitzpatrick, J. Mertz, S. B. Erickson, S. Liggett, S. Popham, D. N. Wochos, A. Synhavsky, S. Hippler, T. S. Larson, et al. Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1288 - 1292. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu, C. E. N. Reiter, D. A. Antonetti, S. R. Kimball, L. S. Jefferson, and T. W. Gardner Insulin Promotes Rat Retinal Neuronal Cell Survival in a p70S6K-dependent Manner J. Biol. Chem., March 5, 2004; 279(10): 9167 - 9175. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Smith, L. E. Wrenshall, R. F. Nicosia, R. Pichler, C. L. Marsh, C. E. Alpers, N. Polissar, and C. L. Davis Delayed Graft Function and Cast Nephropathy Associated with Tacrolimus Plus Rapamycin Use J. Am. Soc. Nephrol., April 1, 2003; 14(4): 1037 - 1045. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |